Evaluation of the Aspheric ReSTOR Intraocular Lens (IOL) After Routine Cataract Extraction
1 other identifier
observational
20
1 country
1
Brief Summary
The purpose of this study is to evaluate the visual outcomes and patient satisfaction after bilateral implantation of the aspheric ReSTOR multifocal intraocular lens (IOL) and compare it to a historical control group of patients implanted bilaterally with the spherical ReSTOR multifocal IOL.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2007
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedFirst Submitted
Initial submission to the registry
November 29, 2007
CompletedFirst Posted
Study publicly available on registry
November 30, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2008
CompletedOctober 4, 2010
October 1, 2010
November 29, 2007
October 1, 2010
Conditions
Keywords
Interventions
Multifocal intraocular lens
Eligibility Criteria
aspheric ReSTOR multifocal intraocular lens (IOL)
You may qualify if:
- Subjects MUST fulfill the following conditions to qualify for enrollment into the trial
- Subject must have an age-related cataract in both eyes.
- years of age or older.
- Patient must desire cataract extraction.
- Expected maximum of 2 weeks and minimum of 1-week interval between first and second eye surgeries.
- Willing and able to comply with scheduled visits and other study procedures.
You may not qualify if:
- Preoperative ocular pathology:
- Amblyopia
- Rubella cataract
- Proliferative diabetic retinopathy
- Shallow anterior chamber
- Macular edema
- Retinal detachment
- Aniridia or iris atrophy
- Uveitis
- History of iritis
- Iris neovascularization
- Medically uncontrolled glaucoma
- Microphthalmus or macrophthalmus
- Optic nerve atrophy
- Macular degeneration (with anticipated best postoperative visual acuity less than 20/30)
- +13 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kerry D Solomon, MD
Medical University of South Carolina, Storm Eye Institute
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 29, 2007
First Posted
November 30, 2007
Study Start
October 1, 2007
Study Completion
September 1, 2008
Last Updated
October 4, 2010
Record last verified: 2010-10